Abbreviation	Interpretation
AE	adverse event
ALK	anaplastic lymphoma kinase
APC	antigen-presenting cell
ASCT	autologous stem-cell transplantation
B2M	beta-2-microglobulin
BTLA	B and T lymphocyte attenuator
CAF	cancer-associated fibroblast
CCR4	C-C chemokine receptor type 4
CD	cluster of differentiation
CD40L	CD40 ligand
cHL	classical Hodgkin lymphoma
CR	complete response
CRC	colorectal cancer
CRR	complete response rate
CSCC	cervical squamous cell carcinoma
CSF-1	colony stimulating factor 1
CTLA-4	cytotoxic T-lymphocyte-associated protein 4
DLT	dose-limiting toxicity
dMMR	DNA mismatch repair-deficient
EGFR	epidermal growth factor receptor
ER	endoplasmic reticulum
FDA	Food and Drug Administration
GAL9	galectin-9
GBM	glioblastoma multiforme
GEJ	gastroesophageal junction
GITR	glucocorticoid-induced tumor necrosis factor receptor
HCC	hepatocellular carcinoma
HL	Hodgkin lymphoma
HLA	human leukocyte antigen
HR	hazard ratio
HVEM	tumor necrosis factor receptor superfamily member 14
ICOS	inducible T-cell co-stimulator
IDO	indoleamine 2,3-dioxygenase
IFN	interferon
IL	interleukin
KIR	killer cell immunoglobulin-like receptors
LAG-3	lymphocyte-activation gene-3
mAb	monoclonal antibody
MCC	Merkel cell carcinoma
M-CSF	macrophage colony-stimulating factor
MDSC	myeloid-derived suppressor cell
MHC	major histocompatibility complex
MSI-H	microsatellite instability-high
MTD	maximum tolerated dose
MɸII	type II macrophage
NK	natural killer
NSCLC	non-small cell lung cancer
NsqNSCLC	non-squamous non-small cell lung cancer
ORR	objective response rate
OS	overall survival
OX40L	OX40 ligand
PD-1	programmed cell death protein-1
PD-L1	programmed death-ligand 1
PD-L2	programmed death-ligand 2
PFS	progression-free survival
PI3K	phosphatidyl-inositol 3-kinase
PRR	partial response rate
RCC	renal cell carcinoma
rrPMBCL	relapsed/refractory primary mediastinal B-cell lymphoma
SCLC	small cell lung cancer
sqNSCLC	squamous non-small cell lung cancer
TAP	transporter associated with antigen processing
TCR	T cell receptor
TGF-β	transforming growth factor-beta
TIM-3	T cell immunoglobulin and mucin-domain containing-3
TME	tumor microenvironment
TNBC	triple-negative breast cancer
TNF	tumor necrosis factor
Treg	regulatory T cell
VEGF	vascular endothelial growth factor